Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lijuan Xu, Fengsen Li, Min Jiang, Zheng Li, Dan Xu, Jing Jing, Jing Wang & Jianbing Ding. (2023) Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 139-153.
Read now
Read now
Monique Martins Melo, Fernanda Ferreira Cruz & Patricia Rieken Macedo Rocco. (2023) Mesenchymal stromal cell therapy for chronic lung diseases: experimental and clinical evidence. Expert Review of Respiratory Medicine 17:3, pages 223-235.
Read now
Read now
Articles from other publishers (10)
Saurabh Kumar, Shama Parveen, Suchit Swaroop & Monisha Banerjee. (2023) TNF-α and MMPs mediated mucus hypersecretion induced by cigarette smoke: An in vitro study. Toxicology in Vitro 92, pages 105654.
Crossref
Crossref
Rui-xia Zhu, Xiu-hong Nie, Xiao-fang Liu, Yong-xiang Zhang, Jin Chen, Xue-jiao Liu & Xin-jie Hui. (2023) Short-term effect of particulate matter on lung function and impulse oscillometry system (IOS) parameters of chronic obstructive pulmonary disease (COPD) in Beijing, China. BMC Public Health 23:1.
Crossref
Crossref
Yong Bum Park, Jin Hwa Lee, Seung Won Ra, Hye Yun Park, Ji Ye Jung, Young Ae Kang, Chin Kook Rhee, Deog Kyeom Kim, Kwang Ha Yoo, Yong Il Hwang, Seong Yong Lim, Jae Seung Lee, Kyung-Wook Jo & Yeon-Mok Oh. (2023) Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey. Tuberculosis and Respiratory Diseases 86:3, pages 196-202.
Crossref
Crossref
Dian Chen, Jeffrey L. Curtis & Yahong Chen. (2023) Twenty years of changes in the definition of early chronic obstructive pulmonary disease. Chinese Medical Journal Pulmonary and Critical Care Medicine 1:2, pages 84-93.
Crossref
Crossref
Shuang Qu & Jing Zhu. (2022) A Nomogram for Predicting Cardiovascular Diseases in Chronic Obstructive Pulmonary Disease Patients. Journal of Healthcare Engineering 2022, pages 1-10.
Crossref
Crossref
N. P. Knyazheskaya, E. Кh. Anaev, A. S. Belevskiy & M. A. Makarova. (2022) Double broncholytic combination of umeclidnium/ vilanterol in COPD therapy: issues of efficacy and safety. Meditsinskiy sovet = Medical Council 16:18, pages 49-54.
Crossref
Crossref
O. Yu. Kytikova, M. V. Antonyuk, T. A. Gvozdenko & T. P. Novgorodtseva. (2022) Diffusing capacity of lungs in chronic obstructive pulmonary disease: gender, age, and race aspects. Bulletin Physiology and Pathology of Respiration:85, pages 116-130.
Crossref
Crossref
Yaw-Syan Fu, Ning Kang, Yanping Yu, Yan Mi, Jialin Guo, Jingyi Wu & Ching-Feng Weng. (2022) Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD. European Respiratory Review 31:164, pages 220028.
Crossref
Crossref
Innokenty Savin, Andrey Markov, Marina Zenkova & Aleksandra Sen’kova. (2022) Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis. Biomedicines 10:5, pages 1017.
Crossref
Crossref
Mauro Finicelli, Filomena Anna Digilio, Umberto Galderisi & Gianfranco Peluso. (2022) The Emerging Role of Macrophages in Chronic Obstructive Pulmonary Disease: The Potential Impact of Oxidative Stress and Extracellular Vesicle on Macrophage Polarization and Function. Antioxidants 11:3, pages 464.
Crossref
Crossref